We investigated the changes in brain oxygen tension (ptiO 2 ) after ventilation with pure O 2 in order to (1) clarify the pathophysiology of O 2 exchange in the cerebral microcirculation; and (2) investigate the relationship between brain O 2 tension, O 2 delivery, and consumption in steady-state conditions during stepwise cerebral blood flow (CBF) reductions. A swine model was developed to reduce CBF in three stable steps: (1) baseline (CBF 100%), (2) CBF of 50-60% of baseline, and (3) CBF of ,30% of baseline. CBF was reduced by infusing saline into the left lateral ventricle through a catheter connected with an infusion pump. At each step, hyperoxia was tested by increasing the inspired oxygen fraction up to 100%, PtiO 2 reflected the CBF reductions, since it was respectively 27.95 (6 10.15), 14.77 (6 3.58), and 3.45 (6 2.89) mm Hg during the three CBF steps. Hyperoxia was followed by an increase in ptiO 2 , although the increase was significantly lower when hyperoxia was applied during progressive ischemia. O 2 supply to the brain did not change during hyperoxia. Arteriovenous oxygen difference (AVDO 2 ) decreased during the phases of intact CBF and moderate impairment, but not during the phase of severe CBF reduction. In conclusion, ptiO 2 reductions closely reflect the imbalance between oxygen delivery and demand; this implies a link between low ptiO 2 and defective O 2 supply due to impaired CBF. However, this relation is not necessarily reciprocal, since manipulating brain oxygen tension does not always influence brain oxygen delivery, as in the case of ventilation with pure oxygen.
INTRODUCTION I
SCHEMIA has been identified as a pathway of cerebral damage after head injury (Graham et al., 1978; Bouma et al., 1991) . Therefore, one of the major aims of research into severe head injury is to achieve a better understanding of how brain metabolism is affected and to assess the adequacy of the transport of oxygen and other energy substrates to the brain parenchyma. This is based on the concept that ensuring cerebral oxygenation and an adequate supply of metabolites is the basis for maintaining the viability and function of the damaged CNS.
Global monitoring provides an indirect estimate of the adequacy of substrate supply to the brain. Brain oxygen tension (ptiO 2 ) can be measured locally using a Clark electrode implanted in the cerebral parenchyma. The method has been validated for use in humans and has been confirmed as a reliable and stable indicator of local oxygenation (Dings et al., 1997 (Dings et al., , 1998 . PtiO 2 monitoring is useful to assess the efficacy of treatments based on their ability to restore adequate ptiO 2 levels (Kiening et al., 1997; Zauner et al, 1997; Stocchetti et al., 1998) .
Interest has been renewed on the effect of arterial hyperoxia, obtained by ventilation with pure oxygen, on brain oxygenation. The ptiO 2 response to hyperoxia varies widely in different patients; it may also vary considerably during the clinical course in head injury (Van Santbrink et al., 1996) . However, the pathophysiology of the oxygen reactivity and the meaning of its variability are not clearly understood. Arterial hyperoxia has been used in order to elucidate its effect on cerebral blood flow (CBF), cerebral metabolism, and their coupling. This procedure markedly increases ptiO 2 and may also enhance O 2 delivery to the neurons (Menzel et al., 1999) .
Our group developed a swine model of stepwise reduction of CBF, structured to achieve three steps of stable CBF: the first is intact CBF, the second a mild CBF reduction, and the third a severe CBF impairment. The model can be used to explore the interactions between ptiO 2 , oxygen delivery and consumption, and blood flow in stable conditions.
The present experiment was designed to investigate the effects of arterial hyperoxia obtained by ventilation with pure oxygen on cerebral oxygenation. Specifically, we sought to gain further insight into the pathophysiology of oxygen exchange in brain tissue during mild and severe CBF impairment while also assessing how changes in brain oxygen tension are related to brain oxygen delivery and consumption when hyperoxia is applied during intact, moderately reduced, or severely impaired CBF.
MATERIALS AND METHODS
The experiments were conducted in accordance with the guidelines for animal research published by the European Union and acknowledged by Italian Law no. 116/92.
Seven 8-week-old domestic pigs, weighing 18-22 kg, were used. They had free access to food and water until the night before the experiment. Thirty minutes before the induction of anesthesia they were given an intramuscular bolus of 100 mg of ketamine. This ensured adequate sedation before general anesthesia, which was induced with propofol (2 mg/kg) and succinylcholine (1 mg/kg) and maintained with isoflurane 1.0%; myorelaxation during the experiment was maintained by 0.3 mg/kg/h pancuronium bromide. An orotracheal tube was positioned, and ventilation was administered with a controlled volume modality to achieve paCO 2 30-35 mm Hg. Inspiratory oxygen fraction (FiO 2 ) was kept at 25% and 30% to obtain a paO 2 of 100-120 mm Hg.
Placement of the Probes and Monitoring
Deep branches of the carotid artery and the jugular vein were surgically exposed and cannulated for monitoring arterial pressure, arterial blood gases, arterial hemoglobin oxygen saturation (SaO 2 ), and infusion of fluids. Saline was infused at the rate of 3 mL/kg/h. Rectal temperature was monitored and kept at 37.5-38.5°C using heating pads. The animals were placed in the prone position and a linear incision was made along the midline from the inion to the nasion. The scalp was exposed, and three burr holes were placed 1.5 cm from the midline on the right side through and across the coronal suture. Two more burr holes were made: one through the sagittal suture and the other through the left coronal suture (1.5 cm from the midline). Through a dural incision in the cerebral parenchyma (from the front to the rear and on the right side), we placed the tips of the CBF probe, the ptiO 2 probe, and the intracranial pressure (ICP) transducer. Through the burr hole on the left, a ventricular catheter was placed and connected to an infusion pump. The burr hole through the sagittal suture gave access to the superior sagittal sinus and was punctured for monitoring venous blood gases and venous hemoglobin oxygen saturation (SsO 2 ). The position of the probes on the skull is illustrated in Figure 1 .
ICP was measured by a parenchymal fiberoptic device (Camino Lab). PtiO 2 was measured by a polarographic Clark-type microcatheter (Licox, GMS). PtiO 2 was allowed to stabilize for 2 h after insertion of the catheter and was corrected for rectal temperature during the experiment. After the ptiO 2 probe was removed, we checked the sensitivity drift, as suggested by the manufacturer. CBF was obtained continuously by laser Doppler flowmetry (Peri-flux, Perimed) and was calculated as the change in signal, as a percentage of the baseline.
Intermittent samples were drawn simultaneously from superior sagittal sinus and from the artery in order to calculate the arteriovenous oxygen difference (AVDO 2 ), as follows:
Hb*1.34*(SaO 2 % 2 SsO 2 %) 1 0.003(paO 2 2 psO 2 ) Oxygen delivery to the brain (DO 2 ) was calculated by multiplying arterial oxygen content by estimated CBF, assuming that the intact CBF amounted to 50 mL/100 g/min. Cerebral electrical activity was monitored by a three-point ROSSI ET AL.
EEG (Cerebro-trac, SDR Medical). Mean arterial pressure (MAP), ICP, cerebral perfusion pressure (CPP), PtiO 2 , end-tidal CO 2 , CBF, and temperature signals were filtered by an analog digital converter (Mac Lab), and stored in a Macintosh computer for offline analysis.
Induction of Progressive Ischemia
The model was developed to achieve progressive CBF reduction in three stable steps: baseline (CBF 100%), CBF 50-60% of baseline, and 20-30% of baseline. CBF was reduced by inducing intracranial hypertension by infusing saline (warmed to 38°C) into the left lateral ventricle through a catheter connected with an infusion pump. ICP was raised stepwise by boluses of saline. Once the end point was reached (in terms of reduction of CPP and CBF), the velocity of fluid infusion into the ventricles was titrated to keep ICP, CPP, and CBF stable during each step. Cushing response elicited by the ICP increase was inhibited by the infusion of a-b blockers (repeated bolus of labetalol 0.5-1 mg/kg).
At the end of the experiment, the animals were euthanized by increasing the isoflurane concentration to 4% and by infusing 60 mEq of KCl.
Hyperoxia Test
During each stage of the experiment (CBF 100%, 50-60%, and 20-30% of baseline), a hyperoxia test was done. Once ICP, CPP, CBF, and ptiO 2 were stable, the inspired oxygen fraction was raised from 25-30% to 100%. Ventilation with pure oxygen was continued until ptiO 2 and the other intracranial parameters plateaued. At the end of the test, FiO 2 was brought back to the starting value.
Statistics
Data were summarized as mean 6 SD. Intracranial and extracranial parameters at the three different CBF values were compared using repeated-measures analysis of variance. A paired t test was used to compare differences between two groups. A p , 0.05 was considered as statistically significant.
RESULTS

Description of the Model
Intracranial and stystemic variables. The course of intracranial variables is shown in Figure 2 . CPP and CBF reduction reflected both the increase in ICP and the slight reduction of MAP as a consequence of the use of a,b blockers to blunt the Cushing reflex. The end points in terms of reduction in CPP and thus in CBF were reached stepwise. The two parameters were stable during the three stages, which lasted (1) and (3) 48.28 (611.32) min. CBF reduction was accompanied by a parallel decrease in O 2 delivery and by a significant increase in AVDO 2 , consistent with impending ischemia (Figure 3 ). The venoarterial difference of paCO 2 (VACO 2 ) confirmed these findings, significantly increasing from 10 (64) mm Hg at the baseline, to 14.5 (64.11) and to 31.2 (69.0) mm Hg in the two subsequent stages (p , 0.01). At the baseline and in the two phases of CBF reduction, blood gases and internal temperature remained constant; there was a small drop in hemoglobin concentration, probably due to frequent blood sampling (Table 1) .
Electroencephalographic findings. Progressive CBF impairment was accompanied by a sustained reduction in EEG amplitude during the first phase (CBF 50-60% of baseline) and by electrical silence during the second (CBF 20-30% of baseline; Figure 4) . PtiO 2 response to ischemia. In seven experiments, eight ptiO 2 catheters were used. One needed to be replaced because of malfunction, probably due to careless storage. The others provided reliable readings throughout the experiment, as confirmed by the final drift check. In all cases the probe was allowed to stabilize for 2 h after insertion. PtiO 2 reflected CBF reductions, since it was 27.95 (610.15) mm Hg with intact CBF. It declined to 14.77 (63.58) mm Hg during the first CBF reduction, dropped to 3.45 (62.89) mm Hg during the second reduction, and finally fell to 0 mm Hg when CBF was completely abolished.
Response to Hyperoxia
PtiO 2 response. Intracranial and extracranial parameters that might have influenced the response to hyperoxia remained stable during the maneuvers (Table 2) . PaO 2 increments caused by ventilation with pure oxygen were not different during the three phases of the experiment. Arterial hyperoxia was followed by a ptiO 2 increase except in one case when ptiO 2 dropped close to 0 mm Hg after severe CBF reduction. PtiO 2 and paO 2 changes during hyperoxia in the three stages of the experiment are presented in Figure 5 . The response of ptiO 2 followed a wash-in curve with an early phase of rapid increase followed by a flex-point and a plateau. In order to standardize our analysis of the behavior of ptiO 2 after arterial hyperoxia, we considered the rise in the first minute after induction of hyperoxia (the phase of the highest response). The increase in ptiO 2 was significantly lower when hyperoxia was applied during CBF reduction, and this was confirmed when the values were corrected for PaO 2 as indicated by the following calculation:
(ptiO 21st minute 2 ptiO 2base )/(paO 2100% 2 paO 2base ) * 100 where ptiO 21st minute is the value after the first minute of hyperoxia, ptiO 2base is the value before hyperoxia, paO 2100% is O 2 arterial partial pressure with ventilation with pure O 2 and paO 2 base is O 2 arterial partial pressure before hyperoxia was induced (Figure 6 ). DO 2 and AVDO 2 . In each of the three steps of the experiment, CBF showed a slight reduction during hyperoxia and a restoration of the original CBF at the end of the hyperoxia test, as indicated in Figure 7 . To clarify whether the increase of ptiO 2 due to hyperoxia reflected an increased oxygen supply, we multiplied the arterial oxygen content by the relative value of the CBF. O 2 supply to the brain did not change during hyperoxia in any of the three steps of the experiment (Figure 8, upper  panel) . We evaluated the effects of arterial and cerebral hyperoxia on oxygen extraction by comparing AVDO 2 during normo-and hyperoxia for the three CBF levels. AVDO 2 decreased significantly during hyperoxia when CBF was normal or mildly reduced; it remained unchanged during severe CBF reduction (Figure 8 , lower panel).
ARTERIAL HYPEROXIA AND BRAIN OXYGENATION
DISCUSSION
Disturbances of oxygen utilization by the brain are a common mechanism of damage after head injury (Bergsneider et al., 1997; Bouma et al., 1991; Cormio et al., 1999; Gopinath et al., 1994) . Like in peripheral tissues, this may be due to inadequate O 2 uptake, inadequate O 2 delivery, or mitochondrial dysfunctions (Pinsky, 1994). These disturbances have been amply reported in the literature and have been associated with unfavorable outcome after head injury. However, a full characterization and description of the pathophysiology of gas exchange and metabolism in the brain is lacking, making it hard to assess the real efficacy of treatments to restore appropriate O 2 delivery. In our experimental model, reduction of CBF was achieved by injecting volume into the ventricular system, a widely described technique (Maas et al., 1993) . The primary aim of the model was to obtain reproducible steps of CBF decline, stable enough to allow the study of PtiO 2 , oxygen delivery and AVDO 2 in response to superimposed perturbations and interventions.
The end points of CPP and CBF reduction were obtained in all the animals studied, with only small variation. The continuous infusion of volume into the system enabled us to maintain the desired CBF reduction and, by administering a,b blockers, we were able to limit the Cushing response, which would tend to raise CBF closer to physiological levels by increasing arterial pressure and heart rate through sympathetic activation. It might be argued that the use of labetalol may have caused an impairment of autoregulation which could have affected cerebral oxygenation. Findings on how the adrenergic system affects cerebrovascular tone are often contradictory, so it is difficult to assess the drug's impact on autoregulation (Go, 1991) . Blunting the Cushing response was essential in this experiment in order to obtain the stepwise CBF reduction, and we do not know what would happen to brain oxygen tension without the a,b blocker.
PtiO2 values in case of intact CBF were around 20 mm Hg; the value declined parallel to the flow reduction, confirming extensive reports about the ptiO 2 threshold for ischemia (Doppenberg et al., 1998; Kiening et al., 1996; Maas et al., 1993; Valadka, 1998) .
During these controlled "staircase" CBF reductions, we were able to estimate brain oxygen delivery. However, as we do not know the absolute value of CBF, the measure had to be extrapolated; nevertheless, with the stable conditions and a global reduction of flow, this extrapolation should give a close approximation of the change in oxygen supply to the brain at different levels of CBF. The symmetrical increase of AVDO 2 further confirms that there are situations where CBF becomes progressively less able to meet the tissue's metabolic demand. AVDO 2 , for instance, was 7.01 (61.31) mL/100 mL during mild reduction of CBF and 8.16 (61.54) mL/100 mL during marked flow reduction, in agreement with the thresholds for ischemia reported elsewhere (Gibbs et al., 1942; Robertson et al., 1989) . Venous-arterial difference in pCO 2 , which has been recently suggested as an indicator of critical hypoperfusion and ischemia, also increased during the three stages of the experiment (Weil et al., 1986; Zhang and Vincent, 1993) .
PtiO 2 increased after the induction of arterial hyperoxia, the extent of this rise depending on the initial CBF value: it was close to 6 mm Hg/min when CBF was intact and fell to 2.6 mm Hg/min when CBF was severely compromised.
Our data on how ptiO 2 reacts to hyperoxia may help clarify the pathophysiology of ptiO 2 readings provided by polarographic sensors when progressive ischemia is induced. Tissue oxygenation depends on the balance between microcirculatory O 2 delivery and parenchymal O 2 demand. The characteristics affecting O 2 response are the permeability of the tissue itself to O 2 (depending on solubility and the O 2 diffusion coefficient) and the spatial distribution and activity of the mitochondria with respect to the source of O 2 (namely arterioles and capillaries; Leach and Treacher, 1998; Treacher and Leach, 1998; Lubbers, 1977; Pittman, 1999) .
The diffusion gradient between the vessels and the tissue should be higher in case of ischemia, so the ptiO 2 response to arterial hyperoxia would be expected to be greater in case of low CBF and low baseline ptiO 2 , which was not the case in our experiment. The different response to hyperoxia during ischemia is thus consistent with an increase in the diffusion distance due to a re-ROSSI ET AL. duction in microvasculature density per unit of tissue. We therefore believe that the importance of the ptiO 2 response to hyperoxia provides further evidence that ptiO 2 readings by the polarographic sensor are primarily the expression of the spatial distribution and of the density of arterioles and capillaries in the parenchyma. We have confirmed the results of this animal study in patients suffering head injury and subarachnoid hemorrhage, in which the ptiO 2 probe was placed in low-flow brain areas (Longhi et al., 1999) .
The second issue we set out to address was the relationship between the changes in ptiO 2 and oxygen de- (CBF in this case). The increase in the O 2 dissolved fraction caused by arterial hyperoxia has a limited impact on O 2 content, which is due mainly to the fraction bound to hemoglobin. Raising paO 2 from 130 to 500 mm Hg increases the O 2 dissolved fraction by only 1.1 mL/dL (to 0.003 *paO 2 ). The second factor affecting O 2 delivery is CBF which decreased (albeit only slightly) after arterial hyperoxia was induced in our experimental setting. This response has already been reported: arterial hyperoxia caused cerebral vasoconstriction, hence a decrease in CBF (Jacobson et al., 1963 (Jacobson et al., , 1964 . It follows that O 2 brain delivery cannot be increased substantially by manipulating the inspired oxygen fraction.
Therefore, we must distinguish between oxygen tension, which responds impressively to changes in inspired oxygen fraction, and oxygen content and delivery, which show a negligible change in response to hyperoxia, but are the key factors for sustaining aerobic metabolism.
It has been recently suggested that increasing ptiO 2 by ventilation with pure oxygen may have a beneficial effect on brain dysoxia (Menzel et al., 1999) . The assumption is that simply increasing ptiO 2 in the tissue might increase the driving force of O 2 flux from the capillary to the mitochondria and might then cause a shift from anaerobic to aerobic metabolism.
Our AVDO 2 data, however difficult to interpret, do not seem to confirm this. AVDO 2 indicates the coupling, or the lack of coupling, between CBF and O 2 metabolism (CMRO 2 ) and clearly illustrated the match/mismatch between O 2 supply and demand during the three phases of intact, moderately and severely impaired CBF. However, at least in the first two phases, AVDO 2 decreased after hyperoxia was induced. The relationship among CBF, CMRO 2 and AVDO 2 can be expressed as AVDO 2 5 CMRO2/CBF. It follows that if AVDO 2 decreases, this may be due to an increase in CBF or a decrease in CMRO 2 . In our conditions, CBF fell slightly during hyperoxia, so a decrease in CMRO 2 may explain the AVDO 2 data. This makes it difficult to find an agreement between the drop in AVDO 2 and the theoretical restoration of oxidative phosphorylation ROSSI ET AL.
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FIG. 8.
Arteriovenous oxygen difference (AVDO 2 ) and brain oxygen delivery (DO 2 ) during normoxia and hyperoxia. *p , 0.05 (paired t test between AVDO 2 in normoxia and in hyperoxia during the same CBF step).
induced by the elevation of ptiO 2 in response to arterial hyperoxia, which would have led to an increase of CMRO 2 .
On the other hand, as CBF declined in line with the institution of hyperoxia, a reduction of CMRO 2 can only be inferred to explain the reduction of AVDO 2 . Impaired glucose uptake and oxidation, probably due to interference with the pyruvate oxidase system, was found during ventilation with oxygen at 1 and 2 atmospheres (Jacobson et al., 1964) . However, we believe that this needs further investigation using more direct methods to study cerebral metabolism.
Besides the results need to be repeated in animals who have undergone traumatic brain injury, since the cerebral metabolic derangements occurring after head trauma, may affect the response to arterial hyperoxia.
In conclusion, ptiO 2 reductions closely reflect the imbalance between oxygen delivery and demand; this implies a link between low ptiO 2 and defective O 2 supply due to impaired CBF. However, this relation is not necessarily reciprocal, since manipulating brain oxygen tension does not always influence brain oxygen delivery, as in the case of ventilation with pure oxygen. Though the effects of arterial hyperoxia on brain metabolism need more study, we believe that for the time being at least the ptiO 2 response to hyperoxia may be useful for investigating O 2 diffusion impairment with respect to the spatial distribution of the brain microvasculature, but not for restoring oxidative metabolism.
